0001655759-23-000020.txt : 20230224
0001655759-23-000020.hdr.sgml : 20230224
20230224165935
ACCESSION NUMBER: 0001655759-23-000020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230222
FILED AS OF DATE: 20230224
DATE AS OF CHANGE: 20230224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cassidy Sean A
CENTRAL INDEX KEY: 0001421914
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38672
FILM NUMBER: 23668411
MAIL ADDRESS:
STREET 1: 322 EAST MAIN STREET
CITY: BRANFORD
STATE: CT
ZIP: 06405
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARVINAS, INC.
CENTRAL INDEX KEY: 0001655759
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472566120
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 WINCHESTER AVE
STREET 2: 5 SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-535-1456
MAIL ADDRESS:
STREET 1: 395 WINCHESTER AVE
STREET 2: 5 SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
FORMER COMPANY:
FORMER CONFORMED NAME: ARVINAS INC.
DATE OF NAME CHANGE: 20181001
FORMER COMPANY:
FORMER CONFORMED NAME: ARVINAS HOLDING COMPANY, LLC
DATE OF NAME CHANGE: 20151015
4
1
wf-form4_167727595596926.xml
FORM 4
X0306
4
2023-02-22
0
0001655759
ARVINAS, INC.
ARVN
0001421914
Cassidy Sean A
C/O ARVINAS, INC.
5 SCIENCE PARK, 395 WINCHESTER AVE.
NEW HAVEN
CT
06511
0
1
0
0
Chief Financial Officer
Common Stock
2023-02-22
4
A
0
19125
0
A
180572
D
Stock Option (right to buy)
34.37
2023-02-22
4
A
0
57450
0
A
2033-02-21
Common Stock
57450.0
57450
D
The restricted stock units (each, an "RSU") were granted by the Issuer on February 22, 2023, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over four years: 1/4 of the shares underlying the award shall vest on February 22, 2024, with the remainder of the shares vesting in equal monthly installments following February 22, 2024 through February 23, 2027.
The option was granted by the Issuer on February 22, 2023, pursuant to the Plan. The shares underlying the option will vest over four years: 1/4 of the shares underlying the award shall vest on February 22, 2024, with the remainder of the shares vesting in equal monthly installments following February 22, 2024 through February 23, 2027.
/s/ Matthew Batters, as attorney-in-fact for Sean Cassidy
2023-02-24